Prosecution Insights
Last updated: April 19, 2026
Application No. 18/856,277

EXPANDABLE INTERVERTEBRAL IMPLANT BY CONICAL SCREW ELEMENT AND SYSTEM

Non-Final OA §102
Filed
Oct 11, 2024
Examiner
LANE, HOLLY JOANNA
Art Unit
3773
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Neo Medical SA
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
3y 0m
To Grant
97%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allow Rate
83 granted / 104 resolved
+9.8% vs TC avg
Strong +17% interview lift
Without
With
+16.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
27 currently pending
Career history
131
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
35.3%
-4.7% vs TC avg
§102
38.9%
-1.1% vs TC avg
§112
23.1%
-16.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 104 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Species XI (Figs. 14A-14F) in the reply filed on 01/06/2026 is acknowledged. Claims 34, 38, 40-42, and 44-50 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Species I-VIII and X-XII, there being no allowable generic or linking claim. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 31-33, 35-37, 39, and 43 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Grotz (US 20160135960 A1). Regarding claim 31, Grotz teaches An expandable implant (see Fig. 12) having an insertion direction to be placed in an intervertebral space, comprising: a first section (upper portions 218, see labelled diagram of Fig. 15 below) having a first bone-engaging surface (223); a second section (lower portions 218, see labelled diagram of Fig. 12 below) having a second bone-engaging surface arranged opposite to the first section (223), the first and second bone-engaging surfaces arranged to be substantially in parallel to the insertion direction (note that the outer sureface of the implant is parallel to the longitudinal axis thereof, see Fig. 12); an interconnection structure (222) interconnecting the first section and the second section (see Fig. 12), at least one portion of the interconnection structure being deformable to allow for a change of a distance and/or orientation between the first section and second section (see Para. [0069]); and a first partial inner cylindrical thread structure (234) arranged between the first section and the second section, the first partial inner cylindrical thread structure having a first thread axis (see Para. [0072]), the first thread axis being oblique to the insertion direction by a first angle alpha (see labelled diagram of Fig. 15 below). PNG media_image1.png 402 528 media_image1.png Greyscale PNG media_image2.png 518 528 media_image2.png Greyscale Regarding claim 32, Grotz teaches the expandable implant of claim 31, further comprising: a first ramped surface facing an open segment of the first partial inner cylindrical thread structure and arranged between the first section and the second section (see labelled diagram of Fig. 15 below), wherein a distance between the first ramped surface and the first partial inner cylindrical thread structure measured in a direction that is perpendicular to the first and second bone-engaging surfaces decreases along the insertion direction (see labelled diagram of Fig. 15 below). PNG media_image3.png 464 645 media_image3.png Greyscale Regarding claim 33, Grotz teaches the expandable implant of claim 32, wherein the first ramped surface forms a cylindrical segment surface having a cylindrical axis that is oblique to the insertion direction by a second angle alpha2 (see labelled diagram of Fig. 15 above). Regarding claim 35, Grotz teaches the expandable implant of claim 31, further comprising: a third partial inner cylindrical thread structure arranged between the first section and the second section, extending next to the first partial inner cylindrical thread structure (see labelled diagram of Fig. 15 above), the third partial inner cylindrical thread structure having a third thread axis, the third thread axis being oblique to the insertion direction by a third angle (see labelled diagram of Fig. 15 above). Regarding claim 36, Grotz teaches the expandable implant of claim 35, further comprising: a second ramped surface facing an open segment of the third partial inner cylindrical thread structure and arranged between the first section and the second section (see labelled diagram of Fig. 15 above), wherein a distance between the second ramped surface and the third partial inner cylindrical thread structure measured in a direction that is perpendicular to the first and second bone-engaging surfaces decreases along the insertion direction (see labelled diagram of Fig. 15 above). Regarding claim 37, Grotz teaches the expandable implant of claim 35, further comprising: a fourth partial inner cylindrical thread structure arranged between the first section and the second section and arranged to face the third partial inner cylindrical thread structure such a third thread pitch of the third partial inner cylindrical thread structure and a fourth thread pitch of the fourth partial inner cylindrical thread structure are matching (see Para. [0072]), the fourth partial inner cylindrical thread structure having a fourth thread axis, the fourth thread axis being oblique to the insertion direction by a fourth angle (see labelled diagram of Fig. 15 above). Regarding claim 39, Grotz teaches the expandable implant of claim 31, further comprising: a first conically-shaped screw element (210) having a first outer thread configured for threadable engagement with the first partial inner cylindrical thread structure (see Para. [0068]). Regarding claim 43, Grotz teaches the expandable implant of claim 31, wherein the interconnection structure (222) is deformable to permit an expansion of a distance D between the upper and lower sections upon threadable engagement of a conical screw element with the first partial inner cylindrical thread structure (see Para. [0069]). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See form PTO-892. Any inquiry concerning this communication or earlier communications from the examiner should be directed to HOLLY J LANE whose telephone number is (703)756-4702. The examiner can normally be reached Monday-Friday 9:00am-5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Eduardo Robert can be reached at 571-272-4719. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /H.J.L./Examiner, Art Unit 3773 /EDUARDO C ROBERT/Supervisory Patent Examiner, Art Unit 3773
Read full office action

Prosecution Timeline

Oct 11, 2024
Application Filed
Feb 03, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582305
LIGHTED DISPOSABLE SPECULUM
2y 5m to grant Granted Mar 24, 2026
Patent 12575723
LIGHTED BOUGIE
2y 5m to grant Granted Mar 17, 2026
Patent 12575866
INTRAMEDULLARY IMPLANT FOR TRANSVERSE OSTEOTOMY
2y 5m to grant Granted Mar 17, 2026
Patent 12569236
DEVICES, SYSTEMS, AND METHODS FOR INSERTING AND REMOVING SURGICAL WIRES
2y 5m to grant Granted Mar 10, 2026
Patent 12564429
ADJUSTABLE IMPLANT, SYSTEM AND METHODS
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
97%
With Interview (+16.9%)
3y 0m
Median Time to Grant
Low
PTA Risk
Based on 104 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month